Faculty:
Jay S. Duker, MD
Director, New England Eye Center
Professor and Chairman of Ophthalmology
Tufts Medical Center
Tufts University School of Medicine
Boston, MA
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
The contents of this activity derive from Retina 2017, which took place on January 16-20, 2017. Disclosures for faculty are accurate as of the time of the live meeting.
Faculty reports the following relationships(s):
Jay S. Duker, MD
Consulting Fee: Alimera, Allergan, Aura Biosciences, Ocudyne, Omeros, Santen, ThromboGenics
Contracted Research: Carl Zeiss Meditec, Optovue, Topcon
Other: Stock Shareholder: Hemera Biosciences, Ophthotech
Board of Directors: Eleven
Reviewers report the following relationship(s):
Ronald A. Codario MD, FACP, FNLA, RPVI, CHCP (Recertification review on 8/9/2018)
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.